An independent examination of the liquid bee-derived metabolism formula featuring berberine, kudzu, royal jelly, and lipase-supporting ingredients from the Ohio-based supplement brand ...

The biotech sector staged a robust comeback in 2025, with the Nasdaq Biotechnology Index climbing 33.8%. Although concerns ...

Targeting SUMOylation in glioblastoma opens new avenue for therapeutic interventions and biomarker discovery Glioblastoma, a ...

A research team has identified a key gene from the rubber tree that helps plants better defend themselves against both ...

Few medicines have sparked as much debate as statins. Cardiologists often describe them as life-saving, while some patients ...

While some studies suggest that apple cider vinegar can reduce the risk of fatty liver disease, the evidence is weak. Learn more about the benefits and risks.

A research-driven evaluation assessing the comparative effectiveness of phosphodiesterase type 5 (PDE5) inhibitors is contributing to ongoing clinical discourse around vascular-mediated functional ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

A new study reveals that antimicrobial resistance is rising worldwide - eroding the effectiveness of last-line antibiotics ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

Gudeta, B. (2025) Comparative Study of Rhodanese Specific Activity Assay Techniques for Plants and Bacterial Species.